Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.
2.

Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody.

McIntyre KW, Stepan GJ, Kolinsky KD, Benjamin WR, Plocinski JM, Kaffka KL, Campen CA, Chizzonite RA, Kilian PL.

J Exp Med. 1991 Apr 1;173(4):931-9.

4.

Interleukin-1 (IL-1) directly and indirectly promotes hematopoietic cell growth through type I IL-1 receptor.

Hestdal K, Ruscetti FW, Chizzonite R, Ortiz M, Gooya JM, Longo DL, Keller JR.

Blood. 1994 Jul 1;84(1):125-32.

6.

Improved survival of lethally irradiated recipient mice transplanted with circulating progenitor cells mobilized by IL-8 after pretreatment with stem cell factor.

Laterveer L, Zijlmans JM, Lindley IJ, Hamilton MS, Willemze R, Fibbe WE.

Exp Hematol. 1996 Oct;24(12):1387-93.

PMID:
8913284
9.
10.
11.

Comparison of in vivo effects of human recombinant IL 1 and human recombinant IL 6 in mice.

Neta R, Vogel SN, Sipe JD, Wong GG, Nordan RP.

Lymphokine Res. 1988 Winter;7(4):403-12.

PMID:
3145371
12.
13.

Failure of IL-1 receptor antagonist and monoclonal anti-IL-1 receptor antibody to inhibit antigen-specific immune responses in vivo.

Faherty DA, Claudy V, Plocinski JM, Kaffka K, Kilian P, Thompson RC, Benjamin WR.

J Immunol. 1992 Feb 1;148(3):766-71.

PMID:
1530956
15.

The immunosuppressant rapamycin blocks in vitro responses to hematopoietic cytokines and inhibits recovering but not steady-state hematopoiesis in vivo.

Quesniaux VF, Wehrli S, Steiner C, Joergensen J, Schuurman HJ, Herrman P, Schreier MH, Schuler W.

Blood. 1994 Sep 1;84(5):1543-52.

16.

alpha-Galactosylceramide (AGL-517) treatment protects mice from lethal irradiation.

Inoue H, Koezuka Y, Nishi N, Osawa M, Motoki K, Kobayashi E, Kabaya K, Obuchi M, Fukushima H, Mori KJ.

Exp Hematol. 1997 Aug;25(9):935-44.

PMID:
9257806
17.

A role for manganese superoxide dismutase in radioprotection of hematopoietic stem cells by interleukin-1.

Eastgate J, Moreb J, Nick HS, Suzuki K, Taniguchi N, Zucali JR.

Blood. 1993 Feb 1;81(3):639-46.

18.
19.
20.

Supplemental Content

Support Center